description
Merck USA index - 14, 7520
form
liquid
specific activity
≥5 units/mg protein
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, avoid repeated freeze/thaw cycles
shipped in
wet ice
storage temp.
−20°C
Quality Level
General description
来自人血浆的天然纤溶酶。催化肽类、精氨酸和赖氨酸酯水解，并将纤维蛋白转化为可溶性产物。
Packaging
请参考特定浓度批号的标签。
Physical form
在100 mM磷酸钠，1 mM 6-氨基己酸，25%甘油，pH值7.3中。
Preparation Note
初次融化后，等分并冷冻（-20°C）。
由经认证测试对 HBsAg 以及 HIV 和 HCV 抗体阴性的血浆制制备而成。
Other Notes
Federici, A.B., et al. 1993.Blood 81, 720.
Hoffmann, J.J., and Janssen, W.C.1992.Thromb.Res. 67, 711.
Hoffmann, J.J., and Janssen, W.C.1992.Thromb.Res. 67, 711.
一个单位定义为在 25°C，pH 7.8 下，每分钟水解 1.0 µ mol N-tosyl-Gly-Pro-Lys-pNA的酶量。
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
仅供研究使用在法国，在用于科研目的时（包括进口和出口活动（《公共健康法》第L 1211-1条，第2节））该产品为管制品。购买者（即最终用户）需要获得《公共健康法》法第L 1211-1条规定的法国研究部的进口授权。订购本产品即表明您确认已经获得合适的进口授权。
毒性：标准处理（A）
存储类别
10 - Combustible liquids
wgk
WGK 2
法规信息
高风险级别生物产品-Merck
此项目有
A B Federici et al.
Blood, 81(3), 720-725 (1993-02-01)
The behavior of plasma von Willebrand factor (vWF) in patients with acute leukemia (n = 5), decompensated cirrhosis (n = 10), and acute pancreatitis (n = 5) was investigated to evaluate whether the systemic proteolytic states associated with these diseases
J J Hoffmann et al.
Thrombosis research, 67(6), 711-719 (1992-09-15)
The mechanisms by which thrombolytic agents affect platelet function are not yet elucidated. The aim of the present study was to investigate the effects of plasmin, generated by thrombolytic agents in plasma, on platelet glycoproteins (GP) Ib and IIb/IIIa. Platelet-rich
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持